NASDAQ: MRKR
Marker Therapeutics Inc Stock Ownership - Who owns Marker Therapeutics?

Insider buying vs selling

Have Marker Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ElmsDirector2024-12-2311,085$3.20
$35.47kBuy
New Enterprise Associates 16 LP10% Owner2024-12-23554,250$3.20
$1.77MBuy

1 of 1

MRKR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRKR insiders and whales buy or sell their stock.

MRKR Shareholders

What type of owners hold Marker Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter W. Sonsini100.05%10,714,285$12.86MInsider
Ali Behbahani100.05%10,714,285$12.86MInsider
Carmen Chang100.05%10,714,285$12.86MInsider
Paul Edward Walker100.05%10,714,285$12.86MInsider
Scott D. Sandell100.05%10,714,285$12.86MInsider
Mohamad Makhzoumi100.05%10,714,285$12.86MInsider
Joshua Makower100.05%10,714,285$12.86MInsider
Anthony A. Florence Jr.100.05%10,714,285$12.86MInsider
Forest Baskett100.05%10,714,285$12.86MInsider
John Robert Wilson72.95%7,812,008$9.37MInsider

1 of 3

MRKR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRKR3.14%96.86%Net Buying
IMNN2.91%63.41%Net Buying
RLMD25.31%3.78%Net Buying
BLRX0.09%0.00%
BRTX0.27%99.73%Net Selling

Marker Therapeutics Stock Ownership FAQ

Who owns Marker Therapeutics?

Marker Therapeutics (NASDAQ: MRKR) is owned by 41.70% institutional shareholders, 1,286.34% Marker Therapeutics insiders, and 0.00% retail investors. Peter W. Sonsini is the largest individual Marker Therapeutics shareholder, owning 10.71M shares representing 100.05% of the company. Peter W. Sonsini's Marker Therapeutics shares are currently valued at $12.75M.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.